Literature DB >> 27219202

Positive predictive value of endometrial polyps in Pipelle aspiration sampling: a histopathological study of 195 cases.

Mimi T Y Seto1, Philip P C Ip2, Siew-Fei Ngu3, Annie N Y Cheung2, Ting-Chung Pun3.   

Abstract

OBJECTIVE: To estimate the positive predictive value of Pipelle endometrial sampling in detecting the presence of an underlying endometrial polyp. The secondary objective is to examine the histologic features that can predict the presence of endometrial polyps. STUDY
DESIGN: This is a retrospective case review study. 195 women who had undergone diagnostic hysteroscopy and/or polypectomy were identified in a University teaching hospital. All patients had a prior polyp diagnosis in the Pipelle endometrial sample. The histology of these samples were compared and analyzed with subsequent DH findings and final hysteroscopic biopsies. Slides were reviewed by 2 gynaecological pathologists.
RESULTS: 162 women were premenopausal (mean age 46.1, SD=4.6) and 33 were postmenopausal (mean age 57.2, SD=8.1). The commonest indication for a Pipelle endometrial sampling was abnormal uterine bleeding. Presence of polyp was confirmed by DH in 56.3% (111/195) cases. Of these, 81.1% (90/111) were confirmed histologically. The positive predictive value of detection of polyps in Pipelle endometrial samples for premenopausal and postmenopausal women was 53.7% and 72.7%, respectively (p=.05). The most reliable histologic features that can predict the presence of an underlying polyp was fibrous stroma (p=.01) and focal glandular clustering (p=.03). The prevalence of endometrial hyperplasia and carcinoma in women who was confirmed to have polyp was 11.7% (13/111).
CONCLUSION: The positive predictive value of Pipelle endometrial samples in detecting endometrial polyps was 56.3%. It was higher in the postmenopausal women (72.7%) compared to premenopausal women (53.7%). The prevalence of endometrial hyperplasia and carcinoma in women who was confirmed to have polyp was consistent with the rate reported in the literature. Using ultrasonography as an adjunct maybe helpful in diagnosing endometrial polyps.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Endometrial polyps; Pipelle endometrial sampler

Mesh:

Year:  2016        PMID: 27219202     DOI: 10.1016/j.ejogrb.2016.04.027

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

Review 1.  Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimens.

Authors:  Philip Pun-Ching Ip
Journal:  Virchows Arch       Date:  2018-02-14       Impact factor: 4.064

2.  Long-term risk of endometrial cancer following postmenopausal bleeding and reassuring endometrial biopsy.

Authors:  Nicole C M Visser; Ellen M Sparidaens; Jan-Willem van den Brink; Maria C Breijer; Erik A Boss; Sebastiaan Veersema; Albert G Siebers; Johan Bulten; Johanna M A Pijnenborg; Ruud L M Bekkers
Journal:  Acta Obstet Gynecol Scand       Date:  2016-10-14       Impact factor: 3.636

3.  Endometrial sampling in low-risk patients with abnormal uterine bleeding: a systematic review and meta-synthesis.

Authors:  Brenda F Narice; Brigitte Delaney; Jon M Dickson
Journal:  BMC Fam Pract       Date:  2018-07-30       Impact factor: 2.497

4.  Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry.

Authors:  Mitzi Aguilar; Hao Chen; Glorimar Rivera-Colon; Shuang Niu; Kelley Carrick; Katja Gwin; Ileana C Cuevas; Subhransu S Sahoo; Hao-Dong Li; Song Zhang; Wenxin Zheng; Elena Lucas; Diego H Castrillon
Journal:  Am J Surg Pathol       Date:  2022-03-01       Impact factor: 6.394

Review 5.  Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer.

Authors:  Milan Milosav Terzic; Gulzhanat Aimagambetova; Sanja Terzic; Melanie Norton; Gauri Bapayeva; Simone Garzon
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.